๐ Weekly Report May 18, 2026 (PDF) โ Download
๐ Podcast May 18, 2026 (MP3) โ Play & Download
iPS Cells & Regenerative Medicine Weekly Report May 18, 2026
- Lonza Reports Strong Q1 2026 Performance, Driven by Robust CDMO Growth and Strategic Transformation into Pure-Play Biopharma Partner
- Hydrogen Energy Weekly Report May 18, 2026
Author of this article
้ข้ฃ่จไบ
-
iPS Cells & Regenerative Medicine Weekly Report October 31, 2026 -
BMS In Vivo CAR-T: Phase 1 Trial Timeline for Autoimmune Diseases
-
ReHeart iPS-derived Heart Muscle: Second Global Surgery at Kyushu University Hospital
-
Kyverna’s miv-cel: Phase 1 data for progressive MS and RMAT status
-
FDA Gene Editing Guidance: BLA Process and IFS Framework 2026
-
Sumitomo Pharma: First iPS-derived Parkinson’s drug transplant
-
Osimertinib Cardiotoxicity: AMPKโLKB1 Signaling and iPSC Models
-
CD73-Targeting CAR-NK Cells: Strategy for Lung Adenocarcinoma
